"In turn, reliance on non-beta-lactam antibiotics, which are often second- or third-line therapy, may be reduced." Of note, the study population included patients with severe immune compromise ...

Pfizer has just completed phase 3 trials of a new antibiotic that's active against ... The year was, say, 2007 (or thereabouts). The unique beta-lactamase inhibitor is avibactam – the first marketed ...

Cefazolin is safe for surgical site infection prophylaxis in orthopedic procedures for patients with beta-lactam allergies, a ...

Unsurprisingly, there are dozens of beta-lactam antibiotics approved for clinical ... complexes from organosilicon compounds, which are non-toxic," explains Tetsuya Inagaki, lead author of the ...